Mindbloom
Mindbloom is a leading consumer psychedelic therapy company dedicated to transforming mental health through innovative treatments like ketamine therapy and future psychedelics such as MDMA and psilocybin. The organization fosters a fast-paced, mission-driven culture focused on excellence, learning, and personal growth. It offers remote work, cutting-edge treatments, and a collaborative environment for passionate individuals committed to mental health reform.
Headquarters
New York, New York, United States
Company Size
201-500 employees
Founded
2018
Mindbloom (Mindbloom Health Inc.) is a licensed telehealth company that provides clinician‑guided, at‑home ketamine therapy programs for depression, anxiety, and PTSD. The platform offers legal, safety‑focused treatment with licensed clinicians, personalized care plans, remote monitoring, and ongoing clinical support. Founded in 2019 and based in New York, Mindbloom emphasizes accessibility and structured, evidence‑informed ketamine‑assisted care delivered remotely.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Mindbloom.
Mindbloom didn’t post a salary, so this is our estimate from similar listings.